Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-23-013012)

Filing Details

Accession Number:: 0000899243-23-013012
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-05-15 20:01:16
Reporting Period:: 2023-05-15

Accepted Time:: 2023-05-15 20:01:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1880438	An2 Therapeutics Inc.	ANTX	Pharmaceutical Preparations (2834)	820606654

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1914503	Eric Easom	C/O An2 Therapeutics, Inc. 1800 El Camino Real, Suite D Menlo Park CA 94027	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-05-15	10,000	$5.38	1,015,766	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,907	Direct
Common Stock	97,058	Indirect	See Footnote
Common Stock	97,058	Indirect	See Footnote

Footnotes

Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
Consists of shares of Common Stock held by the C Easom Irrevocable Trust dated October 8, 2021.
Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.